Preclinical characterization of recombinant human tissue kallikrein-1 as a novel treatment for type 2 diabetes mellitus.
PLoS One
; 9(8): e103981, 2014.
Article
in En
| MEDLINE
| ID: mdl-25100328
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Tissue Kallikreins
/
Diabetes Mellitus, Experimental
/
Diabetes Mellitus, Type 2
/
Hypoglycemic Agents
Type of study:
Prognostic_studies
Limits:
Animals
/
Female
/
Humans
/
Male
Language:
En
Journal:
PLoS One
Journal subject:
CIENCIA
/
MEDICINA
Year:
2014
Document type:
Article
Affiliation country:
Estados Unidos